Skip to main content
Official EU label nameGlossary entry 28343

TAZAROTENE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence
Markets checked
13
Markets with evidence
0
Evidence gaps
13
Resolved identifiers
1

Resolved substance identity

CAS:118292-40-3
Ingredient index records:
TAZAROTENE
Cosmetic functions: SKIN CONDITIONING

3-Pyridinecarboxylic Acid, 6-[(3,4-Dihydro-4,4-Dimethyl-2H-1-Benzothiopyran-6-yl)Ethynyl]-, Ethyl Ester

1 matched or reported name
TAZAROTENE

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name TAZAROTENE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Chemical identity and properties

PubChem 2D chemical structure for CAS 118292-40-3
CAS 118292-40-3PubChem CID 5381

Tazarotene

Tazarotene is the ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin. It has a role as a keratolytic drug, a prodrug and a teratogenic agent. It is an ethyl ester, a member of pyridines, a retinoid, a thiochromane and an acetylenic compound. It is functionally related to a tazarotenic acid. — ChEBI

IUPAC name
ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate
Molecular formula
C21H21NO2S
Molecular weight
351.5 g/mol
Exact mass
351.12930009 Da
XLogP3
4.9
Topological polar surface area
64.5 Ų
Hydrogen-bond donors
0
Hydrogen-bond acceptors
4
Covalent units
1
Defined stereocentres
0

Also known as

TazoracEthyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinateZoracAvageAGN-190168Fabiortazarotenotazarotenum
16 more reported names
Idp-12381BDR9Y8PSARAZLODUOBRII COMPONENT TAZAROTENE3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl esterCHEBI:32184ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)ethynyl)nicotinateethyl 6-[2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl]pyridine-3-carboxylateethyl 6-[(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinateTazaratoneTazarodexEthyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinateethyl 6-(2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl)pyridine-3-carboxylateethyl 6-(2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl)pyridine-3-carboxylatePSO THERARefChem:58033
External database identifiers

Evidence from additional scientific databases

NIH PubChem PUG-View
Exact identifier match5381

Attributed physical-property, hazard, environmental and use annotations.

Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record

Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.

Additional source coverage and match status
SourceResultChecked
NIH PubChem PUG-ViewExact match2026-08-31

A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Take this record further

Screen in a formulaOpen standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision